KAHR medical

About:

KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.

Website: https://kahrbio.com

Top Investors: Sanofi, Pavilion Capital, Dafna Capital Management, Biotechnology Value Fund, HBL Hadasit Bio Holdings

Description:

KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment options for cancer and autoimmune disorders.